Gloria Tavera1, Douglas R Morgan2,3, Scott M Williams1. 1. Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA. 2. Vanderbilt Ingram Cancer Center, Nashville, Tennessee. 3. Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
PURPOSE OF REVIEW: Chronic infection with Helicobacter pylori infection is necessary but not sufficient to initiate development of intestinal-type gastric adenocarcinoma. It is not clear what additional factors tip the scale from commensal bacteria towards a pathogen that facilitates development of gastric cancer. Genetic variants in both the pathogen and host have been implicated, but neither alone explains a substantial portion of disease risk. RECENT FINDINGS: In this review, we consider studies that address the important role of human and bacterial genetics, ancestry and their interactions in determining gastric disease risk. We observe gaps in the current literature that should guide future work to confirm the hypothesis of the interacting roles of host and bacterial genetics that will be necessary to translate these findings into clinically relevant information. SUMMARY: We summarize genetic risk factors for gastric disease in both H. pylori and human hosts. However, genetic variation of one or the other organism in isolation insufficiently explains gastric disease risk. The most promising models of gastric disease risk simultaneously consider the genetic variation of both the H. pylori and human host, under a co-evolution model.
PURPOSE OF REVIEW: Chronic infection with Helicobacter pylori infection is necessary but not sufficient to initiate development of intestinal-type gastric adenocarcinoma. It is not clear what additional factors tip the scale from commensal bacteria towards a pathogen that facilitates development of gastric cancer. Genetic variants in both the pathogen and host have been implicated, but neither alone explains a substantial portion of disease risk. RECENT FINDINGS: In this review, we consider studies that address the important role of human and bacterial genetics, ancestry and their interactions in determining gastric disease risk. We observe gaps in the current literature that should guide future work to confirm the hypothesis of the interacting roles of host and bacterial genetics that will be necessary to translate these findings into clinically relevant information. SUMMARY: We summarize genetic risk factors for gastric disease in both H. pylori and human hosts. However, genetic variation of one or the other organism in isolation insufficiently explains gastric disease risk. The most promising models of gastric disease risk simultaneously consider the genetic variation of both the H. pylori and human host, under a co-evolution model.
Authors: J C Atherton; P M Sharp; T L Cover; G Gonzalez-Valencia; R M Peek; S A Thompson; C J Hawkey; M J Blaser Journal: Curr Microbiol Date: 1999-10 Impact factor: 2.188
Authors: E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin Journal: Nature Date: 2000-03-23 Impact factor: 49.962
Authors: P Correa; C Cuello; E Duque; L C Burbano; F T Garcia; O Bolanos; C Brown; W Haenszel Journal: J Natl Cancer Inst Date: 1976-11 Impact factor: 13.506
Authors: P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki Journal: N Engl J Med Date: 2000-07-13 Impact factor: 91.245
Authors: M F Vaezi; G W Falk; R M Peek; J J Vicari; J R Goldblum; G I Perez-Perez; T W Rice; M J Blaser; J E Richter Journal: Am J Gastroenterol Date: 2000-09 Impact factor: 10.864
Authors: Anna K Miller; Gloria Tavera; Scott M Williams; Douglas R Morgan; Ricardo L Dominguez; M Constanza Camargo; Tim Waterboer; Keith T Wilson Journal: Oncogene Date: 2021-08-10 Impact factor: 9.867
Authors: Ricardo L Dominguez; Charlotte B Cherry; Dago Estevez-Ordonez; Robertino Mera; Veronica Escamilla; Michael Pawlita; Tim Waterboer; Keith T Wilson; Richard M Peek; Gloria Tavera; Scott M Williams; Margaret L Gulley; Michael Emch; Douglas R Morgan Journal: BMC Cancer Date: 2019-06-07 Impact factor: 4.430